MedPath

SANDOZ APREMILAST

SANDOZ APREMILAST

Approved
DIN Number

02529084

Drug Class

Human

Market Date

Nov 18, 2022

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529084
AIG Number0156231002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AA32 APREMILAST
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.24.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

APREMILASTActive
Strength: 30 MG
Monograph: APREMILAST

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.